Maryam Amidi
- Pharmaceutical Science top 0.2%
- Molecular Biology top 10%
- Biomaterials top 1%
- Immunology top 5%
- Biomedical Engineering top 10%
- Co-authors
- Wim E. HenninkWim JiskootEnrico MastrobattistaStefan RomeijnHans E. JungingerGerrit BorchardDaan J.A. CrommelinSima Rahimian
- Topics
- Advanced Drug Delivery Systems (12 papers)RNA Interference and Gene Delivery (11 papers)Immunotherapy and Immune Responses (8 papers)
- Partner nations
- NetherlandsUnited KingdomSwitzerland
In The Last Decade
Maryam Amidi
24 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Pharmaceutical Science 937
- Molecular Biology 918
- Biomaterials 837
- Immunology 517
- Biomedical Engineering 319
Countries citing papers authored by Maryam Amidi
This map shows the geographic impact of Maryam Amidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Amidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Amidi more than expected).
Fields of papers citing papers by Maryam Amidi
This network shows the impact of papers produced by Maryam Amidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Amidi. The network helps show where Maryam Amidi may publish in the future.
Co-authorship network of co-authors of Maryam Amidi
This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Amidi. A scholar is included among the top collaborators of Maryam Amidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Amidi. Maryam Amidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 47 | |
| 4 | 18 | |
| 5 | 90 | |
| 6 | 86 | |
| 7 | 61 | |
| 8 | 19 | |
| 9 | 97 | |
| 10 | 5 | |
| 11 | 40 | |
| 12 | 27 | |
| 13 | 86 | |
| 14 | 179 | |
| 15 | 32 | |
| 16 | 80 | |
| 17 | 43 | |
| 18 | 157 | |
| 19 | 200 | |
| 20 | 325 |
About Maryam Amidi
Maryam Amidi is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (12 papers), RNA Interference and Gene Delivery (11 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Pharmaceutical Science (937 citations), Biomaterials (837 citations) and Molecular Medicine (139 citations). Maryam Amidi has collaborated with scholars based in Netherlands, United Kingdom and Switzerland. Frequent co-authors include Wim E. Hennink, Wim Jiskoot, Enrico Mastrobattista, Stefan Romeijn, Hans E. Junginger, Gerrit Borchard, Daan J.A. Crommelin, Sima Rahimian, Elly van Riet and Rolf J. Verheul. Their work appears in journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.